The health care stocks segment on TrackInsight took a breath of fresh air on Tuesday, March 17th with an average daily performance of 6,02% for the 23 ETFs included in this segment, combined with a large net inflow of $ 460 million recorded on the primary market. This is the third day in a row with positive flows, and the cumulative inflows over the three days surpassed $ 1 bn. The rebound has been supported by the excellent performance of Biotechnology companies after BioNTech SE, a German firm, announced plans overnight to jointly develop and sell a potential coronavirus vaccine with American drugmaker Pfizer. Over the last 30 days, Health Care stocks ETFs lost on average 18% but collected $ 1,3 Bn of new assets. This segment represents $ 29,1 Bn of assets under management.